EMEA (Europe, Middle East and Africa) GABA Receptor Agonist Drug Market Report 2018

March 2018 | 118 pages | ID: E888690F059EN
QYResearch

Abstracts

In this report, the EMEA GABA Receptor Agonist Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of GABA Receptor Agonist Drug for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA GABA Receptor Agonist Drug market competition by top manufacturers/players, with GABA Receptor Agonist Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Advicenne
• AstraZeneca
• Athena Drug Delivery Solutions
• Biocodex
• Elan Corporation
• Eli Lilly and Company
• H.LundBeck, Merck and Co
• GlaxoSmithKline
• NovaDel Pharma
• Novartis
• OVATION Pharmaceuticals
• Osmotica Pharmaceutical
• Pfizer
• sanofi-aventis
• VIVUS
• XenoPort

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Bamaluzole
• Phenibut
• Baclofen
• Gaboxadol
• Klonopin (clonazepam)
• Tiagbine

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Attention Deficit Hyperactivity Disorder (ADHD)
• Psychiatric Disorders and Depression
• Alzheimer
• Epilepsy and Seizure
• Anxiety and Sleep Disorders
• Obesity and Alcoholism

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) GABA Receptor Agonist Drug Market Report 2018

1 GABA RECEPTOR AGONIST DRUG OVERVIEW

1.1 Product Overview and Scope of GABA Receptor Agonist Drug
1.2 Classification of GABA Receptor Agonist Drug
  1.2.1 EMEA GABA Receptor Agonist Drug Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA GABA Receptor Agonist Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Bamaluzole
  1.2.4 Phenibut
  1.2.5 Baclofen
  1.2.6 Gaboxadol
  1.2.7 Klonopin (clonazepam)
  1.2.8 Tiagbine
1.3 EMEA GABA Receptor Agonist Drug Market by Application/End Users
  1.3.1 EMEA GABA Receptor Agonist Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Attention Deficit Hyperactivity Disorder (ADHD)
  1.3.3 Psychiatric Disorders and Depression
  1.3.4 Alzheimer
  1.3.5 Epilepsy and Seizure
  1.3.6 Anxiety and Sleep Disorders
  1.3.7 Obesity and Alcoholism
1.4 EMEA GABA Receptor Agonist Drug Market by Region
  1.4.1 EMEA GABA Receptor Agonist Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of GABA Receptor Agonist Drug (2013-2025)
  1.5.1 EMEA GABA Receptor Agonist Drug Sales and Growth Rate (2013-2025)
  1.5.2 EMEA GABA Receptor Agonist Drug Revenue and Growth Rate (2013-2025)

2 EMEA GABA RECEPTOR AGONIST DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA GABA Receptor Agonist Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA GABA Receptor Agonist Drug Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA GABA Receptor Agonist Drug Revenue and Share by Players (2013-2018)
  2.1.3 EMEA GABA Receptor Agonist Drug Sale Price by Players (2013-2018)
2.2 EMEA GABA Receptor Agonist Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA GABA Receptor Agonist Drug Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA GABA Receptor Agonist Drug Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA GABA Receptor Agonist Drug Sale Price by Type (2013-2018)
2.3 EMEA GABA Receptor Agonist Drug (Volume) by Application
2.4 EMEA GABA Receptor Agonist Drug (Volume and Value) by Region
  2.4.1 EMEA GABA Receptor Agonist Drug Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA GABA Receptor Agonist Drug Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA GABA Receptor Agonist Drug Sales Price by Region (2013-2018)

3 EUROPE GABA RECEPTOR AGONIST DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe GABA Receptor Agonist Drug Sales and Value (2013-2018)
  3.1.1 Europe GABA Receptor Agonist Drug Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe GABA Receptor Agonist Drug Revenue and Growth Rate (2013-2018)
3.2 Europe GABA Receptor Agonist Drug Sales and Market Share by Type
3.3 Europe GABA Receptor Agonist Drug Sales and Market Share by Application
3.4 Europe GABA Receptor Agonist Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe GABA Receptor Agonist Drug Sales Volume by Countries (2013-2018)
  3.4.2 Europe GABA Receptor Agonist Drug Revenue by Countries (2013-2018)
  3.4.3 Germany GABA Receptor Agonist Drug Sales and Growth Rate (2013-2018)
  3.4.4 France GABA Receptor Agonist Drug Sales and Growth Rate (2013-2018)
  3.4.5 UK GABA Receptor Agonist Drug Sales and Growth Rate (2013-2018)
  3.4.6 Russia GABA Receptor Agonist Drug Sales and Growth Rate (2013-2018)
  3.4.7 Italy GABA Receptor Agonist Drug Sales and Growth Rate (2013-2018)
  3.4.8 Benelux GABA Receptor Agonist Drug Sales and Growth Rate (2013-2018)

4 MIDDLE EAST GABA RECEPTOR AGONIST DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East GABA Receptor Agonist Drug Sales and Value (2013-2018)
  4.1.1 Middle East GABA Receptor Agonist Drug Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East GABA Receptor Agonist Drug Revenue and Growth Rate (2013-2018)
4.2 Middle East GABA Receptor Agonist Drug Sales and Market Share by Type
4.3 Middle East GABA Receptor Agonist Drug Sales and Market Share by Application
4.4 Middle East GABA Receptor Agonist Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East GABA Receptor Agonist Drug Sales Volume by Countries (2013-2018)
  4.4.2 Middle East GABA Receptor Agonist Drug Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia GABA Receptor Agonist Drug Sales and Growth Rate (2013-2018)
  4.4.4 Israel GABA Receptor Agonist Drug Sales and Growth Rate (2013-2018)
  4.4.5 UAE GABA Receptor Agonist Drug Sales and Growth Rate (2013-2018)
  4.4.6 Iran GABA Receptor Agonist Drug Sales and Growth Rate (2013-2018)

5 AFRICA GABA RECEPTOR AGONIST DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa GABA Receptor Agonist Drug Sales and Value (2013-2018)
  5.1.1 Africa GABA Receptor Agonist Drug Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa GABA Receptor Agonist Drug Revenue and Growth Rate (2013-2018)
5.2 Africa GABA Receptor Agonist Drug Sales and Market Share by Type
5.3 Africa GABA Receptor Agonist Drug Sales and Market Share by Application
5.4 Africa GABA Receptor Agonist Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa GABA Receptor Agonist Drug Sales Volume by Countries (2013-2018)
  5.4.2 Africa GABA Receptor Agonist Drug Revenue by Countries (2013-2018)
  5.4.3 South Africa GABA Receptor Agonist Drug Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria GABA Receptor Agonist Drug Sales and Growth Rate (2013-2018)
  5.4.5 Egypt GABA Receptor Agonist Drug Sales and Growth Rate (2013-2018)
  5.4.6 Algeria GABA Receptor Agonist Drug Sales and Growth Rate (2013-2018)

6 EMEA GABA RECEPTOR AGONIST DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Advicenne
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 GABA Receptor Agonist Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Advicenne GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 GABA Receptor Agonist Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Athena Drug Delivery Solutions
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 GABA Receptor Agonist Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Biocodex
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 GABA Receptor Agonist Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Biocodex GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Elan Corporation
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 GABA Receptor Agonist Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Elan Corporation GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Eli Lilly and Company
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 GABA Receptor Agonist Drug Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Eli Lilly and Company GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 H.LundBeck, Merck and Co
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 GABA Receptor Agonist Drug Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 GlaxoSmithKline
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 GABA Receptor Agonist Drug Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 GlaxoSmithKline GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 NovaDel Pharma
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 GABA Receptor Agonist Drug Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 NovaDel Pharma GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Novartis
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 GABA Receptor Agonist Drug Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Novartis GABA Receptor Agonist Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 OVATION Pharmaceuticals
6.12 Osmotica Pharmaceutical
6.13 Pfizer
6.14 sanofi-aventis
6.15 VIVUS
6.16 XenoPort

7 GABA RECEPTOR AGONIST DRUG MANUFACTURING COST ANALYSIS

7.1 GABA Receptor Agonist Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of GABA Receptor Agonist Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 GABA Receptor Agonist Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of GABA Receptor Agonist Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA GABA RECEPTOR AGONIST DRUG MARKET FORECAST (2018-2025)

11.1 EMEA GABA Receptor Agonist Drug Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA GABA Receptor Agonist Drug Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA GABA Receptor Agonist Drug Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA GABA Receptor Agonist Drug Price and Trend Forecast (2018-2025)
11.2 EMEA GABA Receptor Agonist Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe GABA Receptor Agonist Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt GABA Receptor Agonist Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa GABA Receptor Agonist Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA GABA Receptor Agonist Drug Sales Forecast by Type (2018-2025)
11.7 EMEA GABA Receptor Agonist Drug Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of GABA Receptor Agonist Drug
Figure EMEA GABA Receptor Agonist Drug Sales Volume (K Pcs) by Type (2013-2025)
Figure EMEA GABA Receptor Agonist Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure Bamaluzole Product Picture
Figure Phenibut Product Picture
Figure Baclofen Product Picture
Figure Gaboxadol Product Picture
Figure Klonopin (clonazepam) Product Picture
Figure Tiagbine Product Picture
Figure EMEA GABA Receptor Agonist Drug Sales Volume (K Pcs) by Application (2013-2025)
Figure EMEA Sales Market Share of GABA Receptor Agonist Drug by Application in 2017
Figure Attention Deficit Hyperactivity Disorder (ADHD) Examples
Table Key Downstream Customer in Attention Deficit Hyperactivity Disorder (ADHD)
Figure Psychiatric Disorders and Depression Examples
Table Key Downstream Customer in Psychiatric Disorders and Depression
Figure Alzheimer Examples
Table Key Downstream Customer in Alzheimer
Figure Epilepsy and Seizure Examples
Table Key Downstream Customer in Epilepsy and Seizure
Figure Anxiety and Sleep Disorders Examples
Table Key Downstream Customer in Anxiety and Sleep Disorders
Figure Obesity and Alcoholism Examples
Table Key Downstream Customer in Obesity and Alcoholism
Figure EMEA GABA Receptor Agonist Drug Market Size (Million USD) by Region (2013-2025)
Figure Europe GABA Receptor Agonist Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe GABA Receptor Agonist Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East GABA Receptor Agonist Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East GABA Receptor Agonist Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa GABA Receptor Agonist Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa GABA Receptor Agonist Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA GABA Receptor Agonist Drug Sales Volume and Growth Rate (2013-2025)
Figure EMEA GABA Receptor Agonist Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA GABA Receptor Agonist Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table EMEA GABA Receptor Agonist Drug Sales Volume (K Pcs) of Major Players (2013-2018)
Table EMEA GABA Receptor Agonist Drug Sales Share by Players (2013-2018)
Figure 2017 GABA Receptor Agonist Drug Sales Share by Players
Figure 2017 GABA Receptor Agonist Drug Sales Share by Players
Figure EMEA GABA Receptor Agonist Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA GABA Receptor Agonist Drug Revenue (Million USD) by Players (2013-2018)
Table EMEA GABA Receptor Agonist Drug Revenue Share by Players (2013-2018)
Table 2017 EMEA GABA Receptor Agonist Drug Revenue Share by Players
Table 2017 EMEA GABA Receptor Agonist Drug Revenue Share by Players
Table EMEA GABA Receptor Agonist Drug Sale Price (USD/Pcs) by Players (2013-2018)
Table EMEA GABA Receptor Agonist Drug Sales (K Pcs) and Market Share by Type (2013-2018)
Table EMEA GABA Receptor Agonist Drug Sales Share by Type (2013-2018)
Figure Sales Market Share of GABA Receptor Agonist Drug by Type (2013-2018)
Figure EMEA GABA Receptor Agonist Drug Sales Market Share by Type (2013-2018)
Table EMEA GABA Receptor Agonist Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA GABA Receptor Agonist Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of GABA Receptor Agonist Drug by Type in 2017
Table EMEA GABA Receptor Agonist Drug Sale Price (USD/Pcs) by Type (2013-2018)
Table EMEA GABA Receptor Agonist Drug Sales (K Pcs) and Market Share by Application (2013-2018)
Table EMEA GABA Receptor Agonist Drug Sales Share by Application (2013-2018)
Figure Sales Market Share of GABA Receptor Agonist Drug by Application (2013-2018)
Figure EMEA GABA Receptor Agonist Drug Sales Market Share by Application in 2017
Table EMEA GABA Receptor Agonist Drug Sales (K Pcs) and Market Share by Region (2013-2018)
Table EMEA GABA Receptor Agonist Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of GABA Receptor Agonist Drug by Region (2013-2018)
Figure EMEA GABA Receptor Agonist Drug Sales Market Share in 2017
Table EMEA GABA Receptor Agonist Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA GABA Receptor Agonist Drug Revenue Share by Region (2013-2018)
Figure Revenue Market Share of GABA Receptor Agonist Drug by Region (2013-2018)
Figure EMEA GABA Receptor Agonist Drug Revenue Market Share Regions in 2017
Table EMEA GABA Receptor Agonist Drug Sales Price (USD/Pcs) by Region (2013-2018)
Figure Europe GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe GABA Receptor Agonist Drug Revenue and Growth Rate (2013-2018)
Table Europe GABA Receptor Agonist Drug Sales (K Pcs) by Type (2013-2018)
Table Europe GABA Receptor Agonist Drug Market Share by Type (2013-2018)
Figure Europe GABA Receptor Agonist Drug Market Share by Type in 2017
Table Europe GABA Receptor Agonist Drug Sales (K Pcs) by Application (2013-2018)
Table Europe GABA Receptor Agonist Drug Market Share by Application (2013-2018)
Figure Europe GABA Receptor Agonist Drug Market Share by Application in 2017
Table Europe GABA Receptor Agonist Drug Sales (K Pcs) by Countries (2013-2018)
Table Europe GABA Receptor Agonist Drug Sales Market Share by Countries (2013-2018)
Figure Europe GABA Receptor Agonist Drug Sales Market Share by Countries (2013-2018)
Figure Europe GABA Receptor Agonist Drug Sales Market Share by Countries in 2017
Table Europe GABA Receptor Agonist Drug Revenue (Million USD) by Countries (2013-2018)
Table Europe GABA Receptor Agonist Drug Revenue Market Share by Countries (2013-2018)
Figure Europe GABA Receptor Agonist Drug Revenue Market Share by Countries (2013-2018)
Figure Europe GABA Receptor Agonist Drug Revenue Market Share by Countries in 2017
Figure Germany GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure France GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure UK GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Russia GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Italy GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Benelux GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East GABA Receptor Agonist Drug Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East GABA Receptor Agonist Drug Sales (K Pcs) by Type (2013-2018)
Table Middle East GABA Receptor Agonist Drug Market Share by Type (2013-2018)
Figure Middle East GABA Receptor Agonist Drug Market Share by Type (2013-2018)
Table Middle East GABA Receptor Agonist Drug Sales (K Pcs) by Applications (2013-2018)
Table Middle East GABA Receptor Agonist Drug Market Share by Applications (2013-2018)
Figure Middle East GABA Receptor Agonist Drug Sales Market Share by Application in 2017
Table Middle East GABA Receptor Agonist Drug Sales Volume (K Pcs) by Countries (2013-2018)
Table Middle East GABA Receptor Agonist Drug Sales Volume Market Share by Countries (2013-2018)
Figure Middle East GABA Receptor Agonist Drug Sales Volume Market Share by Countries in 2017
Table Middle East GABA Receptor Agonist Drug Revenue (Million USD) by Countries (2013-2018)
Table Middle East GABA Receptor Agonist Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East GABA Receptor Agonist Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East GABA Receptor Agonist Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Israel GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure UAE GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Iran GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa GABA Receptor Agonist Drug Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa GABA Receptor Agonist Drug Sales (K Pcs) by Type (2013-2018)
Table Africa GABA Receptor Agonist Drug Sales Market Share by Type (2013-2018)
Figure Africa GABA Receptor Agonist Drug Sales Market Share by Type (2013-2018)
Figure Africa GABA Receptor Agonist Drug Sales Market Share by Type in 2017
Table Africa GABA Receptor Agonist Drug Sales (K Pcs) by Application (2013-2018)
Table Africa GABA Receptor Agonist Drug Sales Market Share by Application (2013-2018)
Figure Africa GABA Receptor Agonist Drug Sales Market Share by Application (2013-2018)
Table Africa GABA Receptor Agonist Drug Sales Volume (K Pcs) by Countries (2013-2018)
Table Africa GABA Receptor Agonist Drug Sales Market Share by Countries (2013-2018)
Figure Africa GABA Receptor Agonist Drug Sales Market Share by Countries (2013-2018)
Figure Africa GABA Receptor Agonist Drug Sales Market Share by Countries in 2017
Table Africa GABA Receptor Agonist Drug Revenue (Million USD) by Countries (2013-2018)
Table Africa GABA Receptor Agonist Drug Revenue Market Share by Countries (2013-2018)
Figure Africa GABA Receptor Agonist Drug Revenue Market Share by Countries (2013-2018)
Figure Africa GABA Receptor Agonist Drug Revenue Market Share by Countries in 2017
Figure South Africa GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Nigeria GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Egypt GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Algeria GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Table Advicenne GABA Receptor Agonist Drug Basic Information List
Table Advicenne GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Advicenne GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Advicenne GABA Receptor Agonist Drug Sales Market Share in EMEA (2013-2018)
Figure Advicenne GABA Receptor Agonist Drug Revenue Market Share in EMEA (2013-2018)
Table AstraZeneca GABA Receptor Agonist Drug Basic Information List
Table AstraZeneca GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AstraZeneca GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure AstraZeneca GABA Receptor Agonist Drug Sales Market Share in EMEA (2013-2018)
Figure AstraZeneca GABA Receptor Agonist Drug Revenue Market Share in EMEA (2013-2018)
Table Athena Drug Delivery Solutions GABA Receptor Agonist Drug Basic Information List
Table Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Athena Drug Delivery Solutions GABA Receptor Agonist Drug Sales Market Share in EMEA (2013-2018)
Figure Athena Drug Delivery Solutions GABA Receptor Agonist Drug Revenue Market Share in EMEA (2013-2018)
Table Biocodex GABA Receptor Agonist Drug Basic Information List
Table Biocodex GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Biocodex GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Biocodex GABA Receptor Agonist Drug Sales Market Share in EMEA (2013-2018)
Figure Biocodex GABA Receptor Agonist Drug Revenue Market Share in EMEA (2013-2018)
Table Elan Corporation GABA Receptor Agonist Drug Basic Information List
Table Elan Corporation GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Elan Corporation GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Elan Corporation GABA Receptor Agonist Drug Sales Market Share in EMEA (2013-2018)
Figure Elan Corporation GABA Receptor Agonist Drug Revenue Market Share in EMEA (2013-2018)
Table Eli Lilly and Company GABA Receptor Agonist Drug Basic Information List
Table Eli Lilly and Company GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eli Lilly and Company GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Eli Lilly and Company GABA Receptor Agonist Drug Sales Market Share in EMEA (2013-2018)
Figure Eli Lilly and Company GABA Receptor Agonist Drug Revenue Market Share in EMEA (2013-2018)
Table H.LundBeck, Merck and Co GABA Receptor Agonist Drug Basic Information List
Table H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure H.LundBeck, Merck and Co GABA Receptor Agonist Drug Sales Market Share in EMEA (2013-2018)
Figure H.LundBeck, Merck and Co GABA Receptor Agonist Drug Revenue Market Share in EMEA (2013-2018)
Table GlaxoSmithKline GABA Receptor Agonist Drug Basic Information List
Table GlaxoSmithKline GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GlaxoSmithKline GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure GlaxoSmithKline GABA Receptor Agonist Drug Sales Market Share in EMEA (2013-2018)
Figure GlaxoSmithKline GABA Receptor Agonist Drug Revenue Market Share in EMEA (2013-2018)
Table NovaDel Pharma GABA Receptor Agonist Drug Basic Information List
Table NovaDel Pharma GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure NovaDel Pharma GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure NovaDel Pharma GABA Receptor Agonist Drug Sales Market Share in EMEA (2013-2018)
Figure NovaDel Pharma GABA Receptor Agonist Drug Revenue Market Share in EMEA (2013-2018)
Table Novartis GABA Receptor Agonist Drug Basic Information List
Table Novartis GABA Receptor Agonist Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Novartis GABA Receptor Agonist Drug Sales Market Share in EMEA (2013-2018)
Figure Novartis GABA Receptor Agonist Drug Revenue Market Share in EMEA (2013-2018)
Table OVATION Pharmaceuticals GABA Receptor Agonist Drug Basic Information List
Table Osmotica Pharmaceutical GABA Receptor Agonist Drug Basic Information List
Table Pfizer GABA Receptor Agonist Drug Basic Information List
Table sanofi-aventis GABA Receptor Agonist Drug Basic Information List
Table VIVUS GABA Receptor Agonist Drug Basic Information List
Table XenoPort GABA Receptor Agonist Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of GABA Receptor Agonist Drug
Figure Manufacturing Process Analysis of GABA Receptor Agonist Drug
Figure GABA Receptor Agonist Drug Industrial Chain Analysis
Table Raw Materials Sources of GABA Receptor Agonist Drug Major Manufacturers in 2017
Table Major Buyers of GABA Receptor Agonist Drug
Table Distributors/Traders List
Figure EMEA GABA Receptor Agonist Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure EMEA GABA Receptor Agonist Drug Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA GABA Receptor Agonist Drug Price (USD/Pcs) and Trend Forecast (2018-2025)
Table EMEA GABA Receptor Agonist Drug Sales (K Pcs) Forecast by Region (2018-2025)
Figure EMEA GABA Receptor Agonist Drug Sales Market Share Forecast by Region (2018-2025)
Table EMEA GABA Receptor Agonist Drug Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA GABA Receptor Agonist Drug Revenue Market Share Forecast by Region (2018-2025)
Table Europe GABA Receptor Agonist Drug Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Europe GABA Receptor Agonist Drug Sales Market Share Forecast by Countries (2018-2025)
Table Europe GABA Receptor Agonist Drug Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe GABA Receptor Agonist Drug Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East GABA Receptor Agonist Drug Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Middle East GABA Receptor Agonist Drug Sales Market Share Forecast by Countries (2018-2025)
Table Middle East GABA Receptor Agonist Drug Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East GABA Receptor Agonist Drug Revenue Market Share Forecast by Countries (2018-2025)
Table Africa GABA Receptor Agonist Drug Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Africa GABA Receptor Agonist Drug Sales Market Share Forecast by Countries (2018-2025)
Table Africa GABA Receptor Agonist Drug Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa GABA Receptor Agonist Drug Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA GABA Receptor Agonist Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure EMEA GABA Receptor Agonist Drug Sales Market Share Forecast by Type (2018-2025)
Table EMEA GABA Receptor Agonist Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure EMEA GABA Receptor Agonist Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources